Skip to main content
David Kelly, MD, Pathology, Birmingham, AL

DavidRKellyMD

Pathology Birmingham, AL

Anatomic Pathology, Clinical Pathology, Pediatric Pathology

Pathologist-in-Chief and Medical Director of Laboratories, Children's of Alabama; Clinical Professor of Pathology, University of Alabama at Birmingham

Dr. Kelly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kelly's full profile

Already have an account?

  • Office

    1600 7th Ave S
    Birmingham, AL 35233
    Phone+1 205-638-9634
    Fax+1 205-638-6869

Education & Training

  • University of Minnesota
    University of MinnesotaSurgical Pathology, 1978 - 1979
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Pathology-Anatomic and Clinical, 1974 - 1978
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 1974

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1975 - 2024
  • TN State Medical License
    TN State Medical License 1974 - 1977
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Pediatric Pathology

Awards, Honors, & Recognition

  • Best Doctors in America Best Doctors, Inc, One Boston Place, 32nd Floor, Boston, MA
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Journal Articles

  • Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: Analysis of oxidative stress in lung fibroblasts.  
    Sorge, C., Pereboeva, L., Westin, E., Kelly, D. R., Harris, W. T., Goldman, F., Bone Marrow Transplant.
  • In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma. A phase 1 study.  
    Pressey, J. G., Adams, J., Harkins, L., Kelly, D., You, Z., Lamb, Jr., L. S., Medicine (Baltimore)., 9/1/2016
  • Quintuplets: 5 Cases of NEC. Are There Other Risk Factors?  
    Nadendla, K., Sutton, A., Kelly, D., Dimmitt, R., Wilkinson, L., Harmon, C., Martin, C., Fetal Pediatr. Pathol., 8/23/2016
  • Join now to see all

Books/Book Chapters

Professional Memberships